Q1 Earnings Forecast for Innospec Issued By Seaport Res Ptn

Innospec Inc. (NASDAQ:IOSP) – Stock analysts at Seaport Res Ptn issued their Q1 2026 EPS estimates for shares of Innospec in a note issued to investors on Tuesday, February 18th. Seaport Res Ptn analyst M. Harrison expects that the specialty chemicals company will post earnings of $1.66 per share for the quarter. The consensus estimate for Innospec’s current full-year earnings is $6.18 per share. Seaport Res Ptn also issued estimates for Innospec’s Q2 2026 earnings at $1.68 EPS, Q3 2026 earnings at $1.76 EPS and Q4 2026 earnings at $1.86 EPS.

Innospec (NASDAQ:IOSP) last posted its earnings results on Tuesday, February 18th. The specialty chemicals company reported $1.41 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.05. The business had revenue of $466.80 million for the quarter, compared to analyst estimates of $447.43 million. Innospec had a net margin of 1.93% and a return on equity of 12.27%.

Separately, StockNews.com cut shares of Innospec from a “strong-buy” rating to a “buy” rating in a research report on Saturday, January 11th.

Innospec Trading Up 0.3 %

NASDAQ:IOSP opened at $103.46 on Thursday. Innospec has a twelve month low of $99.49 and a twelve month high of $133.71. The firm has a market capitalization of $2.58 billion, a price-to-earnings ratio of 72.86 and a beta of 1.09. The firm’s fifty day simple moving average is $110.87 and its 200 day simple moving average is $112.43.

Hedge Funds Weigh In On Innospec

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in Innospec by 16.8% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 89,018 shares of the specialty chemicals company’s stock valued at $9,797,000 after buying an additional 12,825 shares during the last quarter. Westwood Holdings Group Inc. boosted its position in Innospec by 1.1% in the 4th quarter. Westwood Holdings Group Inc. now owns 298,096 shares of the specialty chemicals company’s stock valued at $32,808,000 after buying an additional 3,352 shares during the last quarter. Two Sigma Advisers LP boosted its position in Innospec by 48.5% in the 4th quarter. Two Sigma Advisers LP now owns 10,100 shares of the specialty chemicals company’s stock valued at $1,112,000 after buying an additional 3,300 shares during the last quarter. State of Wyoming boosted its position in Innospec by 167.0% in the 4th quarter. State of Wyoming now owns 1,976 shares of the specialty chemicals company’s stock valued at $217,000 after buying an additional 1,236 shares during the last quarter. Finally, Point72 Asset Management L.P. boosted its position in Innospec by 27.6% in the 4th quarter. Point72 Asset Management L.P. now owns 2,425 shares of the specialty chemicals company’s stock valued at $267,000 after buying an additional 525 shares during the last quarter. 96.64% of the stock is owned by hedge funds and other institutional investors.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.